Francesca Caparrotti

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

Martin J. van den Bent, C. Mircea S. Tesileanu, Wolfgang Wick et al. · The Lancet Oncology · 2021 · 327 citations · Full text

Medicine, Oncology, Pharmacology +16

Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity‐modulated radiotherapy

Francesca Caparrotti, Shao Hui Huang, Lin Lu et al. · Cancer · 2017 · 163 citations

Medicine, Oncology, Radiation Oncology +12

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

Hans‐Georg Wirsching, Ghazaleh Tabatabai, Ulrich Roelcke et al. · Annals of Oncology · 2018 · 86 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences

Minerva Becker, A. Varoquaux, Christophe Combescure et al. · European Radiology · 2017 · 72 citations · Full text

Medicine, Oncology, Radiology +17

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

C. Mircea S. Tesileanu, Wies Vallentgoed, Marc Sanson et al. · Acta Neuropathologica · 2021 · 56 citations · Full text

Medicine, Genetics, Oncology +17